|
Market Closed -
Nasdaq
16:00:00 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 9.810 USD | -7.37% |
|
+5.48% | +25.77% |
Stock exchange
Nasdaq
BCRX 9.810 $
-7.37%
44.96M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| BCRX | 9.810USD | -7.37% | 44.96M $ | ||
CBOE
| BCRX | 9.810USD | -7.32% | 1.53M $ | |
Börse Stuttgart
| BO1 | 8.512EUR | -7.09% | 23.66K € | |
Deutsche Boerse AG
| BO1 | 9.112EUR | +2.84% | 18.22K € | |
Boerse Muenchen
| BO1 | 8.472EUR | -7.95% | 898.03 € | |
Mexican S.E.
| BCRX * | 182.00MXN | -6.67% | 18.2K $ | |
Tradegate
| BO1 | 8.506EUR | -7.42% | 59.54 € | |
Berne S.E.
| BO1 | 8.048CHF | -3.63% | 0 CHF |
Quotes 5-day view: BioCryst Pharmaceuticals, Inc.
Delayed Quote Nasdaq| 2026-08-07 | 2026-08-10 | 2026-08-11 | 2026-08-12 | 2026-08-13 | |
|---|---|---|---|---|---|
| Last | US$9.380 | US$9.840 | US$10.34 | US$10.59 | US$9.810 |
| Volume | 4,383,646 | 4,017,077 | 5,034,052 | 3,865,676 | 4,583,104 |
| Change | +0.86% | +4.90% | +5.08% | +2.42% | -7.37% |
| Opening | US$9.500 | US$9.330 | US$9.860 | US$10.33 | US$10.59 |
| High | US$9.665 | US$9.855 | US$10.59 | US$10.68 | US$10.63 |
| Low | US$9.230 | US$9.280 | US$9.780 | US$10.10 | US$9.700 |
Performance
| 1 day | -7.37% | ||
| 1 week | +5.48% | ||
| Current month | +9.24% | ||
| 1 month | -1.01% | ||
| 3 months | +2.19% | ||
| 6 months | +45.12% | ||
| Current year | +25.77% | ||
| 1 year | +15.01% | ||
| 3 years | +40.75% | ||
| 5 years | -39.26% | ||
| 10 years | +94.64% |
Volumes
marketsDaily volume
4,583,163
Estimated daily volume
4,583,163
Avg. Volume 20 sessions
3,444,671
Daily volume ratio
1.33
Avg. Volume 20 sessions USD
33,792,222.51
Record volume 1
40,095,470
Record volume 2
37,550,050
Record volume 3
37,366,410
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
2,706,116,761
Net sales (USD)
874,837,000
Number of employees
435
Sales / Employee (USD)
2,011,120
Free-Float
94.39 %
Free-Float capitalization (USD)
2,554,320,146
Average Daily Capital Traded
1.25%
Indicators
Moving average 5 days
9.89
Moving average 20 days
9.429
Moving average 50 days
9.399
Moving average 100 days
9.276
Price spread / (MMA5)
+0.82%
Price spread / (MMA20)
-3.89%
Price spread / (MMA50)
-4.19%
Price spread / (MMA100)
-5.44%
STIM
RSI 9 days
74.06
RSI 14 days
66.08
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.37% | +5.48% | +15.01% | +40.75% | 2.71B | ||
| +2.07% | +13.76% | +65.44% | +106.53% | 70.1B | ||
| -0.87% | +0.08% | +36.96% | +65.91% | 54.93B | ||
| -4.50% | -4.69% | +2.82% | +463.22% | 28.89B | ||
| -0.96% | -1.22% | +46.98% | +6.46% | 23.9B | ||
| -0.67% | +1.02% | -18.32% | -13.84% | 23.3B | ||
| -0.59% | +7.88% | +40.87% | -20.56% | 18.77B | ||
| +0.35% | +12.02% | +257.19% | +466.50% | 18.41B | ||
| -1.14% | -3.71% | +19.81% | +611.64% | 16.1B | ||
| +0.46% | -3.05% | +31.49% | +135.18% | 12.48B | ||
| Average | -1.32% | +5.91% | +49.82% | +186.18% | 26.96B | |
| Weighted average by Cap. | -0.40% | +4.11% | +50.63% | +163.76% |
Historical Quotes: BioCryst Pharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
6d3428e768fdc27d4c62f8a87c.eZK0HLY245AFqiDRns0O10pqM9EJMM4-qLp4-oS8Y5c.OuXaU_1pgMdcy3Cy0btpohtSe7dBWPtxw49IgMjjNt1P_Nt47lO531TuYQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 9.810 | 497,399 | 3,823,595 |
| 15:59:59 | 9.810 | 200 | 3,326,196 |
| 15:59:59 | 9.810 | 100 | 3,325,996 |
| 15:59:58 | 9.805 | 100 | 3,325,896 |
| 15:59:58 | 9.805 | 200 | 3,325,796 |
| 15:59:57 | 9.805 | 100 | 3,325,596 |
| 15:59:57 | 9.805 | 100 | 3,325,496 |
| 15:59:57 | 9.805 | 163 | 3,325,396 |
| 15:59:57 | 9.805 | 100 | 3,325,233 |
| 15:59:57 | 9.805 | 100 | 3,325,133 |
Course Extremes
| 1 week | 9.28 | 10.68 | |
| 1 month | 8.76 | 10.68 | |
| Current year | 6.23 | 11.22 | |
| 1 year | 6 | 11.22 | |
| 3 years | 4.03 | 11.31 | |
| 5 years | 4.03 | 19.99 | |
| 10 years | 1.38 | 19.99 |
Monthly variations
Annual variations
| 2026 | +25.77% | ||
| 2025 | +3.72% | ||
| 2024 | +25.54% | ||
| 2023 | -47.82% | ||
| 2022 | -17.11% | ||
| 2021 | +85.91% | ||
| 2020 | +115.94% | ||
| 2019 | -57.25% | ||
| 2018 | +64.36% | ||
| 2017 | -22.43% | ||
| 2016 | -38.66% | ||
| 2015 | -15.13% | ||
| 2014 | +60.00% | ||
| 2013 | +435.21% | ||
| 2012 | -42.51% | ||
| 2011 | -52.22% | ||
| 2010 | -19.97% | ||
| 2009 | +371.53% | ||
| 2008 | -77.83% | ||
| 2007 | -46.54% | ||
| 2006 | -30.99% | ||
| 2005 | +189.79% | ||
| 2004 | -15.62% | ||
| 2003 | +613.54% | ||
| 2002 | -75.76% | ||
| 2001 | -40.23% | ||
| 2000 | -77.54% | ||
| 1999 | +321.43% | ||
| 1998 | 0.00% | ||
| 1997 | -57.25% | ||
| 1996 | +77.03% | ||
| 1995 | +100.00% | ||
| 1994 | -28.85% |
- Stock Market
- Stocks
- BCRX Stock
- Quotes BioCryst Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions

















